corpuls Product Portfolio Expanded -- MEDICA - World Forum for Medicine


GS-Elektromedizinische Geräte G. Stemple GmbH

corpuls Product Portfolio Expanded

The company GS Elektromedizinische Geräte G. Stemple GmbH is introducing today its new handy corpuls1 defibrillator/patient monitor at the RETTmobil in Fulda. The device is particularly small, lightweight and multifunctional and has been specifically developed to meet the requirements of fire fighters, first responders, patient transports and emergency management.

The new corpuls1 scores with its compactness and low weight (2.2 kg) without having to make compromises with regard to defibrillation and monitoring.

On the 5.7“ colour screen, up to three curves of the 6-lead ECG, the plethysmogram, and up to four vital parameters can be displayed and monitored. Available vital parameters are the heart rate, SpO2, PP, PI, SpCO, SpHb and SpMet. The oximetry measurement with Masimo Rainbow® SET Technology is non-invasive.
The pre-connected defibrillation electrodes are immediately ready for use and are compatible with the corpuls3.

More Safety for the Rescue Team
The corpuls1 does not only offer the possibility to immediately and easily treat and monitor the patient, but also provides an enormous safety advantage for rescue teams of fire fighters and emergency management. By means of the SpCO measurement, possible carbon monoxide poisoning of the rescue staff can be diagnosed quickly and easily during the mission and so counter measures can be initiated early on.

Secure and Ergonomic Transport
The functional brackets guarantee a secure transport in the vehicle. On the way to the emergency site, the corpuls1 can be carried comfortably with the shoulder strap. The necessary cables, sensors and accessories are stored in the convenient bags on the device.

Versatile Data Management
All measured date are stored in the device and can be exported via SD memory card or via LAN. In connection with the telemedicine solution corpuls.web, the corpuls1 enhances the early diagnostic possibilities with seriously ill patients.

The device will be available at the end of the year.